REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro Oftalmologico Lynd Newball S.A.S (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Support Activities for Road Transportation | Other Ambulatory Health Care Services
Full name: Centro Oftalmologico Lynd Newball S.A.S Profile Updated: December 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Centro Oftalmologico Lynd Newball S.A.S is an enterprise based in Colombia. Its main office is in San Andres. It operates in the Ambulatory Health Care Services sector. The company was established on March 03, 2010. From the latest financial highlights, Centro Oftalmologico Lynd Newball S.A.S reported a net sales revenue increase of 25.25% in 2023. Its’ total assets recorded a growth of 16.09%. The net profit margin of Centro Oftalmologico Lynd Newball S.A.S increased by 2.84% in 2023.

Headquarters
Ak 2 4 93 Piso 5
San Andres; San Andres y Providencia;

Contact Details: Purchase the Centro Oftalmologico Lynd Newball S.A.S report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centro Oftalmologico Lynd Newball S.A.S report to view the information.
Incorporation Date:
March 03, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro Oftalmologico Lynd Newball S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
25.25%
Total operating revenue
25.25%
Operating profit (EBIT)
75.26%
EBITDA
50.52%
Net Profit (Loss) for the Period
62.23%
Total assets
16.09%
Total equity
19.54%
Operating Profit Margin (ROS)
5.66%
Net Profit Margin
2.84%
Return on Equity (ROE)
4.37%
Debt to Equity Ratio
0.2%
Quick Ratio
0.51%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?